Submit Deal

MYLAN NV

Summary

Mylan is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Deals Overview

Total Deals3

Valued Deals2

Total Value£ 18.21 B

Avg. Deal Size£ 9.10 B

Market Context

Subsidiaries

ALPHAPHARM

1 transaction

Sort

24 Apr 2015|Ireland|Pharmaceuticals

Target: PERRIGO COMPANY PLC

Bidder: MYLAN NV

7 Service Providers

3 Target | 4 Bidder

2 Dealmakers

2 Bidder

n/a

Value

20 May 2019|Mauritius|Pharmaceuticals

Target: ASPEN GLOBAL INCORPORATED

Bidder: ALPHAPHARM

5 Service Providers

2 Target | 2 Bidder | 1 Vendor

8 Dealmakers

2 Target | 4 Bidder | 2 Vendor

£ 102 M

Value

29 Jul 2019|United States|Pharmaceuticals

Target: UPJOHN

Bidder: MYLAN NV

20 Service Providers

1 Target | 9 Bidder | 10 Vendor

144 Dealmakers

1 Target | 78 Bidder | 65 Vendor

£ 18.11 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy